Source: Annual Congress 2006 - Epidemiological and clinical aspects of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Bilgin, M. Yalcinsoy, A. Baran, O. Sogukpinar, S. Gungor, B. B. Afsar, E. Akkaya (Istanbul, Turkey). Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 4876

Member's Comments

No comment yet.

Related content which might interest you: Delays in diagnosis and treatment of patients with smear-positive pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005 A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Time course of sputum positivity during chemotherapy in smear-positive pumonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Performance of RD-1 based blood assays in clinical management of smear-negative pulmonary and extra-pulmonary tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 The rational chemotherapy of new smear-positive lung tuberculosis with extended cavitary disease Source: Eur Respir J 2006; 28: Suppl. 50, 9s Year: 2006 Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002 Therapy of the patients with culture-positive pulmonary tuberculosis: doctors compliance Source: Eur Respir J 2006; 28: Suppl. 50, 304s Year: 2006 Cough improves earlier than sputum after treatment initiation in hospitalised patients with pulmonary tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings Source: Eur Respir J 2014; 43: 185-194 Year: 2004 Factors influencing sputum conversion among smear-positive pulmonary tuberculosis patients in Morocco Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Factors influencing time to sputum conversion in smear-positive pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005 Evaluation of relapse and defaulter pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 Supervised and induced sputum among patients with smear-negative pulmonary tuberculosis Source: Eur Respir J 2008; 31: 1085-1090 Year: 2008